Mitchell Finer is the founder of Oncorus. Oncorus has raised $141M in total funding. Latest round: Series B. Based in Cambridge, MA, US.
Mitchell H. Finer is a co-founder of ElevateBio, where he previously served as President of Research & Development and CEO of Life Edit Therapeutics. Prior to ElevateBio, he was the Chief Scientific Officer of bluebird bio, leading the development of approved products like Abecma and Zynteglo. He has also been involved with multiple other cell and gene therapy companies, including Oncorus.
Full founder directory · Investor directory · Company funding database · Fundraising library